{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:42:36Z","timestamp":1782963756308,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1053\/j.akdh.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:53:14Z","timestamp":1757778794000},"page":"373-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Acute Tubulointerstitial Nephritis"],"prefix":"10.1053","volume":"32","author":[{"given":"Namrata","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5830-9663","authenticated-orcid":false,"given":"Fernando","family":"Caravaca-Font\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.akdh.2025.03.002_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ckj\/sfv053","article-title":"Granulomatous interstitial nephritis","volume":"8","author":"Shah","year":"2015","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1053\/j.akdh.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","article-title":"Acute interstitial nephritis: clinical features and response to corticosteroid therapy","volume":"19","author":"Clarkson","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5414\/CN10838","article-title":"Acute interstitial nephritis - a reappraisal and update","volume":"82","author":"Raghavan","year":"2014","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ndt\/gfs143","article-title":"Increased prevalence of acute tubulointerstitial nephritis","volume":"28","author":"Goicoechea","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute tubulointerstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-016-3394-5","article-title":"Tubulointerstitial nephritis: diagnosis, treatment, and monitoring","volume":"32","author":"Joyce","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfu326","article-title":"Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury","volume":"30","author":"Praga","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib8","first-page":"3","article-title":"Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment","volume":"9","author":"Krishnan","year":"2015","journal-title":"Iran J kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993-2011: a case series","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.akdh.2025.03.002_bib10","series-title":"Core Concepts in Parenchymal Kidney Disease","first-page":"329","article-title":"Acute Interstitial Nephritis","author":"Appel","year":"2014"},{"issue":"11","key":"10.1053\/j.akdh.2025.03.002_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.akdh.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41581-022-00630-8","article-title":"Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury","volume":"18","author":"Sprangers","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10157-021-02131-7","article-title":"Acute kidney injury in cancer patients","volume":"26","author":"Liu","year":"2022","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2025.03.002_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003467","article-title":"Acute kidney injury in patients treated with immune checkpoint inhibitors","volume":"9","author":"Gupta","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1053\/j.akdh.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2215\/CJN.00990119","article-title":"The incidence, causes, and risk factors of acute kidney injury in patients receiving immune checkpoint inhibitors","volume":"14","author":"Seethapathy","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000525561","article-title":"Facing the challenge of drug-induced acute interstitial nephritis","volume":"147","author":"Sanchez-Alamo","year":"2023","journal-title":"Nephron"},{"issue":"8","key":"10.1053\/j.akdh.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2025.03.002_bib18","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/j.ekir.2024.09.026","article-title":"Clinicopathological characteristics and kidney outcomes in biopsy-confirmed acute interstitial nephritis","volume":"9","author":"Miao","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1053\/j.akdh.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.01330213","article-title":"Utility of urine eosinophils in the diagnosis of acute interstitial nephritis","volume":"8","author":"Muriithi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2025.03.002_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5414\/CN108301","article-title":"Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician","volume":"81","author":"Perazella","year":"2014","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2025.03.002_bib21","first-page":"558","article-title":"Acute kidney injury in interstitial nephritis","volume":"25","author":"Caravaca-Font\u00e1n","year":"2019","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"10.1053\/j.akdh.2025.03.002_bib22","first-page":"179","article-title":"The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis","volume":"54","author":"Schwarz","year":"2000","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib23","first-page":"55","article-title":"Prediction of the long-term outcome in acute interstitial nephritis","volume":"22","author":"Kida","year":"1984","journal-title":"Clin Nephrol"},{"issue":"6172","key":"10.1053\/j.akdh.2025.03.002_bib24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/bmj.1.6172.1182-a","article-title":"Recurrent acute renal failure due to antibiotic-induced interstitial nephritis","volume":"1","author":"Saltissi","year":"1979","journal-title":"Br Med J"},{"issue":"206","key":"10.1053\/j.akdh.2025.03.002_bib25","first-page":"194","article-title":"Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose corticosteroid therapy","volume":"52","author":"Pusey","year":"1983","journal-title":"Q J Med"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.kint.2019.07.022","article-title":"Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?","volume":"97","author":"Perazella","year":"2020","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.akdh.2025.03.002_bib27","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2215\/CJN.01390118","article-title":"Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis","volume":"13","author":"Fernandez-Juarez","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12882-021-02372-4","article-title":"Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial","volume":"22","author":"Mose","year":"2021","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2025.03.002_bib29","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.ki.5002776","article-title":"Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis","volume":"73","author":"Gonz\u00e1lez","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib30","first-page":"233","article-title":"Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids","volume":"10","author":"Prendecki","year":"2017","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ndt\/5.2.94","article-title":"Acute interstitial nephritis: a clinical and morphological study in 27 patients","volume":"5","author":"Buysen","year":"1990","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2025.03.002_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1440-1797.2012.01648.x","article-title":"Acute tubulointerstitial nephritis, treatment with steroid and impact on renal outcomes","volume":"17","author":"Raza","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"8","key":"10.1053\/j.akdh.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.34067\/KID.0008342021","article-title":"Should Corticosteroids Be Used To Treat Biopsy-proven Drug-induced Acute Interstitial Nephritis?: COMMENTARY","volume":"3","author":"Praga","year":"2022","journal-title":"Kidney360"},{"issue":"3","key":"10.1053\/j.akdh.2025.03.002_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/1319-2442.235171","article-title":"Drug-induced acute interstitial nephritis: prospective randomized trial comparing oral steroids and high-dose intravenous pulse corticosteroid therapy in guiding the treatment of this condition","volume":"29","author":"Chowdry","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2215\/CJN.01711105","article-title":"Mycophenolate mofetil for the treatment of interstitial nephritis","volume":"1","author":"Preddie","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10S","key":"10.1053\/j.akdh.2025.03.002_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1681\/ASN.20203110S189d","article-title":"Use of azathioprine in treating severe corticosteroid-resistant acute interstitial nephritis: PO0102","volume":"31","author":"Lodhi","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000187253","article-title":"Relapsing steroid-responsive idiopathic acute interstitial nephritis","volume":"63","author":"Enriquez","year":"1993","journal-title":"Nephron"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ckj\/sfaa018","article-title":"Recurrent acute interstitial nephritis: what lies beneath","volume":"14","author":"Caravaca-Font\u00e1n","year":"2021","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1053\/j.akdh.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ndt\/gfx247","article-title":"Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China","volume":"33","author":"Su","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.akdh.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00262-022-03140-5","article-title":"Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials","volume":"71","author":"Gu","year":"2022","journal-title":"Cancer Immunol Immunother"},{"issue":"8175","key":"10.1053\/j.akdh.2025.03.002_bib41","article-title":"Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis","volume":"363","author":"Xu","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1681\/ASN.2019070676","article-title":"Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study","volume":"31","author":"Cortazar","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ekir.2018.10.017","article-title":"Immune check point inhibitor-associated glomerulonephritis","volume":"4","author":"Ashour","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.akdh.2025.03.002_bib44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.ajkd.2019.04.016","article-title":"Renal vasculitis and pauci-immune glomerulonephritis associated with immune checkpoint inhibitors","volume":"74","author":"Gallan","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.akdh.2025.03.002_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10157-023-02344-y","article-title":"Immune checkpoint inhibitor-associated acute kidney injury in patients with cancer: a systematic review and meta-analysis of risk factors","volume":"27","author":"Yan","year":"2023","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000538274","article-title":"Association of proton pump inhibitor use and immune checkpoint inhibitor-mediated acute kidney injury: a meta-analysis and a review of related outcomes","volume":"55","author":"Mohan","year":"2024","journal-title":"Am J Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2025.03.002_bib47","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ckj\/sfac161","article-title":"'Prevention is better than cure': warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury","volume":"15","author":"Belliere","year":"2022","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1053\/j.akdh.2025.03.002_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.xkme.2020.05.015","article-title":"Renal tubular acidosis and immune checkpoint inhibitor therapy: an immune-related adverse event of PD-1 inhibitor-A report of 3 cases","volume":"2","author":"Herrmann","year":"2020","journal-title":"Kidney Med"},{"issue":"11","key":"10.1053\/j.akdh.2025.03.002_bib49","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/ndt\/gfae184","article-title":"Immune checkpoint inhibitor-associated nephritis-treatment standard","volume":"39","author":"Barbir","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib50","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ekir.2021.01.013","article-title":"Biomarkers, clinical features, and rechallenge for immune checkpoint inhibitor renal immune-related adverse events","volume":"6","author":"Isik","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006222","article-title":"Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis","volume":"11","author":"Sise","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1053\/j.akdh.2025.03.002_bib52","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ekir.2022.11.020","article-title":"Cytokines and immune cell phenotype in acute kidney injury associated with immune checkpoint inhibitors","volume":"8","author":"Farooqui","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.34067\/KID.0000152019","article-title":"Acute interstitial nephritis and checkpoint inhibitor therapy: single center experience of management and drug rechallenge","volume":"1","author":"Manohar","year":"2020","journal-title":"Kidney360"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002292","article-title":"Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study","volume":"9","author":"Lee","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1877415","article-title":"Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis","volume":"10","author":"Lin","year":"2021","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1053\/j.akdh.2025.03.002_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005646","article-title":"Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI","volume":"10","author":"Gupta","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1053\/j.akdh.2025.03.002_bib57","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00296-018-4118-x","article-title":"Renal involvement in primary Sjogren's syndrome: a prospective cohort study","volume":"38","author":"Jain","year":"2018","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40744-020-00264-x","article-title":"Renal disease in primary sj\u00f6gren's syndrome","volume":"8","author":"Aiyegbusi","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"9","key":"10.1053\/j.akdh.2025.03.002_bib59","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2215\/CJN.00980209","article-title":"Renal involvement in primary Sj\u00f6gren's syndrome: a clinicopathologic study","volume":"4","author":"Maripuri","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2025.03.002_bib60","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.akdh.2025.03.002_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2024.06.006","article-title":"Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis","volume":"127","author":"Liu","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1053\/j.akdh.2025.03.002_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","article-title":"Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients","volume":"88","author":"Mah\u00e9vas","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1053\/j.akdh.2025.03.002_bib63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfac227","article-title":"Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial","volume":"38","author":"Mahevas","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2025.03.002_bib64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.12659\/AJCR.900701","article-title":"A rare case of tubulointerstitial nephritis and uveitis syndrome treated with a multi-specialty approach","volume":"17","author":"Purt","year":"2016","journal-title":"Am J Case Rep"},{"key":"10.1053\/j.akdh.2025.03.002_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.12659\/AJCR.892788","article-title":"A report of an adult case of tubulointerstitial nephritis and uveitis (TINU) syndrome, with a review of 102 Japanese cases","volume":"16","author":"Matsumoto","year":"2015","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2215\/CJN.02540313","article-title":"Tubulointerstitial nephritis with uveitis in Chinese adults","volume":"9","author":"Li","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2025.03.002_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2215\/CJN.09051209","article-title":"Modified C-reactive protein might be a target autoantigen of TINU syndrome","volume":"6","author":"Tan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2025.03.002_bib68","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000507668","article-title":"Acute kidney injury relevant to tubulointerstitial nephritis with late-onset uveitis superimposed by thrombotic microangiopathy: a case report and review of the literature","volume":"6","author":"Zhao","year":"2020","journal-title":"Kidney Dis (Basel)"},{"issue":"6","key":"10.1053\/j.akdh.2025.03.002_bib69","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0272-6386(99)70006-5","article-title":"Course and outcome of tubulointerstitial nephritis and uveitis syndrome","volume":"34","author":"Takemura","year":"1999","journal-title":"Am J Kidney Dis"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813925000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813925000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:42:09Z","timestamp":1758688929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813925000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2949813925000497"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2025.03.002","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Acute Tubulointerstitial Nephritis","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}